English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Meghmani Organics Q3 PAT up 45.6% at Rs69.34cr on lower material costs and exceptional gainsqrcode

−− Meghmani Organics reported 25.94% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs657.66cr

Feb. 16, 2021

Favorites Print
Forward
Feb. 16, 2021

Meghmani Organics Q3 PAT up 45.6% at Rs69.34cr on lower material costs and exceptional gains

Meghmani Organics reported 25.94% growth in total revenues for the Dec-20 quarter on consolidated basis at Rs657.66cr. Among the various speciality chemicals sub-segments, Meghmani showed positive growth in revenues in agrochemicals and chlor alkali derivatives. However, the pigments business saw negative sales growth due to weak industrial demand.


The consolidated Profit after tax (PAT) for the Dec-20 quarter was up 45.64% at Rs69.34cr. On the one hand, the cost of materials grew much slower than the sales growth. The company also benefited from Rs6.50cr as fire insurance compensation in the quarter. As a result, the PAT margins improved from 9.12% in Dec-19 to 10.54% in Dec-20.


Financial highlights for Dec-20 compared yoy and sequentially


5.png

Source: IIFL

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe India Special Biweekly to send news related to your mailbox